EXTRAMEDULLARY PLASMACYTOMA
Clinical trials for EXTRAMEDULLARY PLASMACYTOMA explained in plain language.
Never miss a new study
Get alerted when new EXTRAMEDULLARY PLASMACYTOMA trials appear
Sign up with your email to follow new studies for EXTRAMEDULLARY PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough-to-treat myeloma: combo therapy targets tumors outside bones
Disease control OngoingThis study tests a combination of four drugs (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) in 41 people with multiple myeloma that has spread outside the bones (extramedullary disease). The goal is to see if this stronger treatment can shrink or control these har…
Matched conditions: EXTRAMEDULLARY PLASMACYTOMA
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: EXTRAMEDULLARY PLASMACYTOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 09:00 UTC